Resistance Mechanisms in ROS1-Positive Lung Cancer: New Insight into a Rare but Clinically Important Entity

被引：2
作者：
von Itzstein, Mitchell S. [1 ,2 ]
Gerber, David E. [1 ,2 ,3 ,4 ]
机构：
[1] Univ Texas Southwestern Med Ctr, Dept Internal Med, Div Hematol Oncol, Dallas, TX USA
[2] Univ Texas Southwestern Med Ctr, Harold C Simmons Canc Ctr, Dallas, TX USA
[3] Univ Texas Southwestern Med Ctr, Peter ODonnell Jr Sch Publ Hlth, Dallas, TX USA
[4] Univ Texas Southwestern Med Ctr, Div Hematol Oncol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA
来源：
CLINICAL CHEMISTRY | 2024年 / 70卷 / 04期
关键词：
D O I：
10.1093/clinchem/hvae021
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：571 / 573
页数：3
相关论文
共 50 条
  • [21] High prevalence of concomitant oncogene mutations in prospectively identified patients with ROS1-positive metastatic lung cancer
    Wiesweg, M.
    Eberhardt, W. E. E.
    Reis, H.
    Ting, S.
    Savvidou, N.
    Skiba, C.
    Herold, T.
    Christoph, D. C.
    Meiler, J.
    Worm, K.
    Kasper, S.
    Theegarten, D.
    Hense, J.
    Hager, T.
    Darwiche, K.
    Oezkan, F.
    Welter, S.
    Stuschke, M.
    Kuehl, H.
    Schmid, K. W.
    Schuler, M.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 167 - 167
  • [22] ROS1-Positive Non-Small Cell Lung Cancer: Real-World Data in Korea
    Ahn, B. C.
    Park, S.
    Lim, S. W.
    Kim, H. R.
    Hong, M. H.
    Cho, B. C.
    Ahn, M.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S458 - S458
  • [23] Detection of ROS1-positive non-small cell lung cancer on cytological specimens using immunocytochemistry
    Vlajnic, Tatjana
    Savic, Spasenija
    Barascud, Audrey
    Baschiera, Betty
    Bihl, Michel
    Grilli, Bruno
    Herzog, Michelle
    Rebetez, Julien
    Bubendorf, Lukas
    [J]. CANCER CYTOPATHOLOGY, 2018, 126 (06) : 421 - 429
  • [24] Differential crizotinib efficacy among ROS1 fusion partners in ROS1-positive non-small cell lung cancer.
    Lu, Shun
    Li, Ziming
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [25] Crizotinib inhibition of ROS1-positive tumours in advanced non-small-cell lung cancer: a Canadian perspective
    Bebb, D. G.
    Agulnik, J.
    Albadine, R.
    Banerji, S.
    Bigras, G.
    Butts, C.
    Couture, C.
    Cutz, J. C.
    Desmeules, P.
    Ionescu, D. N.
    Leigh, N. B.
    Melosky, B.
    Morzycki, W.
    Rashid-Kolvear, F.
    Sekhon, H. S.
    Smith, A. C.
    Stockley, T. L.
    Torlakovic, E.
    Xu, Z.
    Tsao, M. S.
    [J]. CURRENT ONCOLOGY, 2019, 26 (04) : E551 - E557
  • [26] INCREMENTAL EFFECTIVENESS OF CRIZOTINIB FOR TREATING ROS1-POSITIVE ADVANCED NON-SMALL-CELL LUNG CANCER IN PORTUGAL
    Saramago, P.
    Hirst, A.
    Iadeluca, L.
    Saraiva, F.
    Ines, M.
    [J]. VALUE IN HEALTH, 2020, 23 : S421 - S421
  • [27] Safety and efficacy of WX-0593 in ALK-positive or ROS1-positive non-small cell lung cancer
    Shi, Y-K.
    Fang, J.
    Zhang, S.
    Liu, Y.
    Wang, L.
    Si, M.
    Ge, M.
    Geng, H.
    [J]. ANNALS OF ONCOLOGY, 2019, 30
  • [28] Characteristics and Outcome of ROS1-Positive Non-Small Cell Lung Cancer Patients in Routine Clinical Practice
    Park, Sehhoon
    Ahn, Beung-Chul
    Lim, Sung Won
    Sun, Jong-Mu
    Kim, Hye Ryun
    Hong, Min Hee
    Lee, Se-Hoon
    Ahn, Jin Seok
    Park, Keunchil
    La Choi, Yoon
    Cho, Byoung Chul
    Ahn, Myung-Ju
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (09) : 1373 - 1382
  • [29] Clinicopathological characteristics and outcome of advanced ROS1-positive non-small cell lung cancer in Asian patients
    Kho, C. Y. X.
    Lim, D. W-T.
    Tan, D. S. W.
    Tan, W. L.
    Rajasekaran, T.
    Jain, A.
    Toh, C. K.
    Ang, M-K.
    Tan, E. H.
    Ng, Q. S.
    [J]. ANNALS OF ONCOLOGY, 2019, 30
  • [30] Taletrectinib vs repotrectinib in ROS1-positive (ROS1+) nonesmall cell lung cancer (NSCLC): A matching-adjusted indirect comparison (MAIC)
    Nagasaka, M.
    Liu, G.
    Pennell, N.
    Ohe, Y.
    Perol, M.
    Li, S.
    Chen, M.
    Bazhenova, L.
    Zhou, C.
    [J]. ANNALS OF ONCOLOGY, 2024, 35 : S1640 - S1641
12345